Literature DB >> 11403268

Skin lesions--an indicator of disease activity in systemic lupus erythematosus?

R D Zecević1, D Vojvodić, B Ristić, M D Pavlović, D Stefanović, D Karadaglić.   

Abstract

Cutaneous manifestations have great diagnostic value for systemic lupus erythematosus (SLE). In this study we tried to establish a correlation between lupus erythematosus LE-specific and LE-nonspecific cutaneous lesions and disease activity measured by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Sixty-six patients with SLE were evaluated. They were divided into three groups having: (1) only LE-specific lesions (38 or 58.46%); (2) only LE-nonspecific lesions (4 or 6.15%); and (3) both types of lesions (23 or 35.38%). Results were analyzed using the Student t-test. Patients with LE-nonspecific skin manifestations had significantly increased disease activity compared to those with only LE-specific lesions. The number of different skin lesion types also correlated with disease activity. It was significantly increased in a group with three different types of lesion, either specific or nonspecific. Patients with only one type of lesion had mild disease. An intermediate disease activity was found in the group with two different lesion types. Lupus-specific skin manifestations serve primarily as an important diagnostic clue. In conclusion, patients with LE-nonspecific lesions have significantly more active SLE than those with LE-specific lesions and may therefore require more intensive therapy and disease monitoring.

Entities:  

Mesh:

Year:  2001        PMID: 11403268     DOI: 10.1191/096120301675962535

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Prognosis of patients with systemic lupus erythematosus and discoid lesions.

Authors:  Thelma Larocca Skare; Bárbara Stadler; Emilio Weingraber; Diogo F De Paula
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

Review 3.  Reviewing the recommendations for lupus in children.

Authors:  Zehra Serap Arıcı; Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

4.  Skin lesions in lupus erythematosus: a marker of systemic involvement.

Authors:  Nilay Kanti Das; Rathindra Nath Dutta; Sujit Ranjan Sengupta
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

Review 5.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01

6.  Clinicopathological and Immunological Profile of Patients with Cutaneous Manifestations and their Relationship with Organ Involvement in Systemic Lupus Erythematosus Attending a Tertiary Care Center of Eastern India.

Authors:  Arghya P Ghosh; Falguni Nag; Saugato Biswas; Raghavendra Rao; Abhishek De
Journal:  Indian J Dermatol       Date:  2020 Jan-Feb       Impact factor: 1.494

7.  Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center.

Authors:  Alakes Kumar Kole; Alakendu Ghosh
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

8.  Interventions for cutaneous disease in systemic lupus erythematosus.

Authors:  Cora W Hannon; Collette McCourt; Hermenio C Lima; Suephy Chen; Cathy Bennett
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09

Review 9.  Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

Authors:  Jucélio Pereira Moura Filho; Raiza Luna Peixoto; Lívia Gomes Martins; Sillas Duarte de Melo; Ligiana Leite de Carvalho; Ana Karine F da Trindade C Pereira; Eutilia Andrade Medeiros Freire
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.